These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7892894)

  • 21. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.
    Rautio A; Boman K; Gerstein HC; Hernestål-Boman J; Lee SF; Olofsson M; Mellbin LG
    Diab Vasc Dis Res; 2017 Jul; 14(4):345-352. PubMed ID: 28403644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of specific hormones on fibrinolysis in pregnancy.
    Houlihan CM; Knuppel RA; Vintzileos AM; Guo JZ; Hahn DW
    Am J Obstet Gynecol; 1996 Jul; 175(1):168-72. PubMed ID: 8694045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of intermittent pneumatic compression during cesarean delivery on fibrinolysis.
    Reddick KL; Smrtka MP; Grotegut CA; James AH; Brancazio LR; Swamy GK
    Am J Perinatol; 2014 Oct; 31(9):735-40. PubMed ID: 24338119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
    Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II.
    Spitz B; Magness RR; Cox SM; Brown CE; Rosenfeld CR; Gant NF
    Am J Obstet Gynecol; 1988 Nov; 159(5):1035-43. PubMed ID: 3189434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A; Kobayashi T; Terao T
    Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
    Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
    Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
    Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
    Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin and venous occlusion: effects on blood fibrinolytic activity and tissue-type plasminogen activator levels.
    Hammouda MW; Moroz LA
    Thromb Res; 1986 Apr; 42(1):73-82. PubMed ID: 3085277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
    Estellés A; Gilabert J; España F; Aznar J; Galbis M
    Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of prostacyclin and fibrinolysis modulators by endothelial cells cultured in the presence of polyethylene terephthalate.
    Cenni E; Ciapetti G; Cavedagna D; Di Leo A; Pizzoferrato A
    J Biomed Mater Res; 1993 Sep; 27(9):1161-4. PubMed ID: 8126014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in ovarian cancer.
    Ho CH; Yuan CC; Liu SM
    Gynecol Oncol; 1999 Dec; 75(3):397-400. PubMed ID: 10600296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous acetylsalicylic acid--dose-related effects on platelet function and fibrinolysis in healthy males.
    Husted SE; Kristensen SD; Vissinger H; Mørn B; Schmidt EB; Nielsen HK
    Thromb Haemost; 1992 Aug; 68(2):226-9. PubMed ID: 1412171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation.
    Kessler CM; Hirsch DR; Jacobs H; MacDougall R; Goldhaber SZ
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):437-46. PubMed ID: 8839995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.